Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2535311000168112 | Rivastigmine (Apo) (rivastigmine 3 mg) capsule, 28 capsules, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2535321000168117 | Rivastigmine (Apo) 3 mg capsule, 28, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rivastigmine (Apo) 3 mg capsule, 28, blister pack | Is a | Rivastigmine (Apo) 3 mg capsule, 28 | true | Inferred relationship | Some | ||
| Rivastigmine (Apo) 3 mg capsule, 28, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Rivastigmine (Apo) 3 mg capsule, 28, blister pack | has TPUU | Rivastigmine (Apo) 3 mg capsule | true | Inferred relationship | Some | 1 | |
| Rivastigmine (Apo) 3 mg capsule, 28, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Rivastigmine (Apo) 3 mg capsule, 28, blister pack | has TP | Rivastigmine (Apo) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR